Lacoxa 50mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism contributes to its efficacy in reducing seizure frequency. Lacoxa is typically administered orally, with dosing individualized based on patient response and tolerability. The 50mg dosage provides a convenient starting point for titration. Clinical studies have demonstrated that lacosamide is generally well tolerated, with common adverse effects including dizziness, headache, nausea, and fatigue. It is important to monitor patients for signs of cardiac conduction abnormalities, as lacosamide may prolong PR interval. Caution is advised in patients with preexisting cardiac conditions. Lacoxa should be used under medical supervision, with consideration of potential drug interactions, particularly with other antiepileptic drugs and medications affecting cardiac conduction. Regular follow-up is recommended to assess therapeutic response and adjust dosage accordingly. Overall, Lacoxa 50mg Tablet offers an effective and well-tolerated option for managing partial-onset seizures in epilepsy patients.